Protocol for in vitro phagocytosis assay for primary mouse microglia and human embryonic stem cell-derived microglia

Beika Zhu1, Alicia L Thurber1, Xianhua Piao2

  • 1Weill Institute for Neuroscience, University of California, San Francisco, San Francisco, CA 94158, USA.

STAR Protocols
|November 25, 2025
PubMed

Insights

This study details a new protocol to measure how well microglia, the brain's immune cells, engulf amyloid-beta (Aβ) peptides. This method helps researchers understand brain health and neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are crucial for brain health, clearing waste like amyloid-beta (Aβ).
  • Dysfunctional microglia contribute to neurodegenerative diseases.
  • Assessing Aβ clearance by microglia is vital for understanding disease mechanisms.

Purpose of the Study:

  • To present a standardized protocol for quantifying Aβ phagocytosis by microglia.
  • To enable real-time assessment of Aβ uptake in primary and stem cell-derived microglia.
  • To provide a reproducible method for neuroinflammation research.

Main Methods:

  • Utilizing an in vitro phagocytosis assay with pHrodo-labeled oligomeric Aβ.
  • Employing the Incucyte SX5 system for real-time signal detection.
  • Describing microglia culture, Aβ labeling, and phagocytosis quantification procedures.

Main Results:

  • The protocol allows for quantitative assessment of Aβ phagocytosis over time.
  • It is applicable to both primary mouse microglia and human iPSC-derived microglia.
  • The method provides reliable data for studying microglial function.

Conclusions:

  • This protocol offers a robust tool for investigating microglial phagocytic function in vitro.
  • It facilitates research into the role of microglia in Aβ clearance and neurodegeneration.
  • The standardized method aids in the development of therapeutic strategies targeting microglial function.

Related Concept Videos